MPLT MapLight Therapeutics, Inc.
Healthcare$29.46+2.47%ClosedMarket Cap: $23.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.26
P/S
0.00
EV/EBITDA
0.13
DCF Value
$0.93
FCF Yield
-723.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-69.1%
ROA
-47.6%
ROIC
-51.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-64.5M | $-60.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-83.4M | $-79.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-169.1M | $-161.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-31.5M | $-29.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-30.7M | $-29.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-23.5M | $-22.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-22.8M | $-21.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-82.9M | $-77.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-20.9M | $-19.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-20.0M | $-18.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-19.3M | $-18.9M | $— | — |
| FY null | $0.00 | -Infinity% | $-57.3M | $-55.7M | $— | — |